期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 較慢,18-36周

Transboundary and Emerging Diseases brings together in one place the latest research on infectious diseases considered to hold the greatest economic threat to animals and humans worldwide. The journal provides a venue for global research on their diagnosis, prevention and management, and for papers on public health, pathogenesis, epidemiology, statistical modeling, diagnostics, biosecurity issues, genomics, vaccine development and rapid communication of new outbreaks. Papers should include timely research approaches using state-of-the-art technologies. The editors encourage papers adopting a science-based approach on socio-economic and environmental factors influencing the management of the bio-security threat posed by these diseases, including risk analysis and disease spread modeling. Preference will be given to communications focusing on novel science-based approaches to controlling transboundary and emerging diseases. The following topics are generally considered out-of-scope, but decisions are made on a case-by-case basis (for example, studies on cryptic wildlife populations, and those on potential species extinctions):

Pathogen discovery: a common pathogen newly recognised in a specific country, or a new pathogen or genetic sequence for which there is little context about — or insights regarding — its emergence or spread.

Prevalence estimation surveys and risk factor studies based on survey (rather than longitudinal) methodology, except when such studies are unique. Surveys of knowledge, attitudes and practices are within scope.

Diagnostic test development if not accompanied by robust sensitivity and specificity estimation from field studies.

Studies focused only on laboratory methods in which relevance to disease emergence and spread is not obvious or can not be inferred (“pure research” type studies).

Narrative literature reviews which do not generate new knowledge. Systematic and scoping reviews, and meta-analyses are within scope.

《跨界和新興疾病》匯集了對(duì)全球動(dòng)物和人類造成最大經(jīng)濟(jì)威脅的傳染病的最新研究成果。該期刊為全球有關(guān)其診斷、預(yù)防和管理的研究提供了一個(gè)平臺(tái)，也為有關(guān)公共衛(wèi)生、發(fā)病機(jī)制、流行病學(xué)、統(tǒng)計(jì)建模、診斷、生物安全問(wèn)題、基因組學(xué)、疫苗開(kāi)發(fā)和新疫情快速通報(bào)的論文提供了一個(gè)平臺(tái)。論文應(yīng)包括使用最先進(jìn)技術(shù)的及時(shí)研究方法。編輯鼓勵(lì)論文采用基于科學(xué)的方法研究影響這些疾病造成的生物安全威脅管理的社會(huì)經(jīng)濟(jì)和環(huán)境因素，包括風(fēng)險(xiǎn)分析和疾病傳播建模。將優(yōu)先考慮以控制跨界和新興疾病的新型科學(xué)方法為重點(diǎn)的通信。以下主題通常被認(rèn)為超出范圍，但會(huì)根據(jù)具體情況做出決定（例如，對(duì)隱蔽野生動(dòng)物種群的研究和對(duì)潛在物種滅絕的研究）：

病原體發(fā)現(xiàn)：在特定國(guó)家新發(fā)現(xiàn)的常見(jiàn)病原體，或一種新的病原體或基因序列，關(guān)于其出現(xiàn)或傳播的背景或見(jiàn)解很少。

基于調(diào)查（而非縱向）方法的患病率估計(jì)調(diào)查和風(fēng)險(xiǎn)因素研究，除非此類研究是獨(dú)一無(wú)二的。知識(shí)、態(tài)度和實(shí)踐調(diào)查在范圍內(nèi)。

如果沒(méi)有從實(shí)地研究中獲得可靠的敏感性和特異性估計(jì)，則進(jìn)行診斷測(cè)試開(kāi)發(fā)。

僅關(guān)注實(shí)驗(yàn)室方法的研究，其中與疾病出現(xiàn)和傳播的相關(guān)性不明顯或無(wú)法推斷（“純研究”類型的研究）。

不會(huì)產(chǎn)生新知識(shí)的敘述性文獻(xiàn)綜述。系統(tǒng)評(píng)價(jià)和范圍評(píng)價(jià)以及薈萃分析均在范圍內(nèi)。

《Transboundary And Emerging Diseases》(跨界和新發(fā)疾病)編輯部通訊方式為WILEY-BLACKWELL PUBLISHING, INC, COMMERCE PLACE, 350 MAIN ST, MALDEN, USA, MA, 02148。如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。